Clinical studies Despite their thriving role in the treatment of obesity 214 , only seven studies investigated the effects of GLP-1RAs in eating disorders (Table 6), including some on their psychopathology in comorbid obesity 215,216,217 and others specifically in binge-eating disorder (BED) 217,218,219,220 , and we could not find any ongoing trial in this area
Factors such as appetite changes, gastrointestinal tolerance, energy levels, and progress are carefully monitored
One single price every month, with everything included
Patients choose ghk-cu peptide injections because they offer both aesthetic and wellness-related advantages
These effects typically peak in the first few weeks and diminish as your body adapts